MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas. Stopfer LE, Rettko NJ, Leddy O, Mesfin JM, et al. Proc Natl Acad Sci U S A 2022;119:e2208900119.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stopfer LE, Rettko NJ, Leddy O, Mesfin JM, et al. MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas. Proc Natl Acad Sci U S A 2022;119:e2208900119.
PMID: 36454758